Log in

Relevant bibliographies by topics / Diabetes Mellitu / Journal articles

To see the other types of publications on this topic, follow the link: Diabetes Mellitu.

Journal articles on the topic 'Diabetes Mellitu'

Author: Grafiati

Published: 4 June 2021

Last updated: 9 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diabetes Mellitu.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sofiana, Rosita, and Sutikno Sutikno. "Optimization of Backpropagation for Early Detection of Diabetes Mellitu." International Journal of Electrical and Computer Engineering (IJECE) 8, no. 5 (October 1, 2018): 3232. http://dx.doi.org/10.11591/ijece.v8i5.pp3232-3237.

Full text

Abstract:

Diabetes mellitus is one of the urgent health problems in the world. Diabetes is a condition primarily defined by the level of hyperglycemia giving rise to risk of micro vascular damage. Those who suffer from this disease generally do not realize and tend to overlook the early symptoms. Late recognition of these early symptoms may drive the disease to a more concerning level. One solution to solve this problem is to create an application that may perform early detection of diabetes mellitus so that it does not grow larger. In this article, a new method in performing early detection of diabetes mellitus is suggested. This method is backpropagation with three optimization namely early initialization with Nguyen-Widrow algorithm, learning rate adaptive determination, and determination of weight change by applying momentum coefficient. The observation is conducted by collecting 150 data consisting of 79 diabetes mellitus patient and 71 non diabetes mellitus patient data. The result of this study is the suggested algorithm succeeds in detecting diabetes mellitus with accuracy rate of 99.33%. Optimized backpropagation algorithm may allow the training process goes 12.4 times faster than standard backpropagation.

APA, Harvard, Vancouver, ISO, and other styles

2

G.A., Akhmedov. "Значимость аутоантител при инсулинзависимом сахарном диабете." Kazanskiy meditsinskiy zhurnal 98, no. 4 (2017): 519–21. http://dx.doi.org/10.17750/kmj2017-519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kudlová, Pavla, and Ilona Kočvarová. "Knowledge and self-assessment of general practitioner nurses in the area of diabetes mellitus." Kontakt 22, no. 3 (August 28, 2020): 165–71. http://dx.doi.org/10.32725/kont.2020.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Becerra, Jose E., Muin J. Khoury, Jose F. Cordero, and J. David Erickson. "Diabetes Mellitus During Pregnancy and the Risks for Specific Birth Defects: A Population-Based Case-Control Study." Pediatrics 85, no. 1 (January 1, 1990): 1–9. http://dx.doi.org/10.1542/peds.85.1.1.

Full text

Abstract:

Although the excess risk for birth defects among children of mothers with diabetes mellitus is well documented, there are few data concerning the risk for specific malformations. In the Atlanta Birth Defects Case-Control Study, those risks for malformations were evaluated. The population-based study included 4929 live and stillborn babies with major malformations ascertained by the Metropolitan Atlanta Congenital Defects Program in the first year of life born to residents of Metropolitan Atlanta between 1968 and 1980. The study also included 3029 nonmalformed live babies who were frequency-matched to case babies by race, period of birth, and hospital of birth. The relative risk for major malformations among infants of mothers with insulin-dependent diabetes mellitu (n = 28) was 7. (5% confidence interval [CI]1.9, 33.5) compared with infants of nondiabetic mothers. The relative risks for major central nervous system and cardiovascular system defects were 15.5 (95% CI = 3.3, 73.8) and 18.0 (95% CI = 3.9, 82.5), respectively. The absolute risks for major, central nervous system, and cardiovascular system malformations among infants of diabetic mothers were 18.4, 5.3, and 8.5 per 100 live births, respectively. Infants of mothers with gestational diabetes mellitus who required insulin during the third trimester of pregnancy were 20.6 (95% CI = 2.5, 168.5) times more likely to have major cardiovascular system defects than infants of nondiabetic mothers. The absolute risk for infants of this group of diabetic mothers was 9.7%. No statistically significant differences were found among infants of mothers with gestational diabetes mellitus who did not require insulin during pregnancy. These results suggest a stronger association than previously reported between maternal diabetes mellitus and specific categories of major malformations and implicate gestational diabetes mellitus as a risk factor for major cardiovascular system defects.

APA, Harvard, Vancouver, ISO, and other styles

5

Hermayanti, Diah, and Erlin Nursiloningrum. "HIPERGLIKEMIA PADA ANAK." Saintika Medika 13, no. 1 (March 28, 2018): 25. http://dx.doi.org/10.22219/sm.v13i1.5443.

Full text

Abstract:

Pendahuluan Diabetes mellitus (DM) merupakan penyakit metabolik ditandai oleh hiperglikemia yang disebabkan berkurangnya produksi atau kerja insulin. DM dapat menyerang anak-anak. Kami melaporkan kasus hiperglikemia pada anak berusia 9 tahun dengan kadar C-peptida dalam batas normal. KasusAnak perempuanberusia 9 tahun, dibawa ke rumah sakit dikeluhkan lemah badan selama satu minggu. Pasien juga dikeluhkan sering kencing terutama di malam hari selama sebulan dan bekas kencing dirubung oleh semut. Pemeriksaan fisik dalam batas normal. Pemeriksaan laboratorium hari pertama : hemoglobin 14,8 g/dl, leukosit 9.860 sel/ul, trombosit 297.000 sel/ul, gula darah acak 328 mg/dl. Pemeriksaan hari kedua : gula darah puasa 274 mg/dl, gula darah 2 jam post prandial 370 mg/dl, dan glukosuria. Pemeriksaan C-Peptida 2,74 ng/ml (normal 1,1 – 4,4 ng/ml)PembahasanPada pasien anak ini ditemukan gejala khas diabetes yaitu fatigue dan poliuri. Pada pemeriksaan laboratorium didapatkan hiperglikemia. Sesuai dengan pedoman dari PERKENI pasien ini didiagnosis sebagai DM, yaitu tipe-1, dengan diferential diagnosis Maturity onset diabetes of the young (MODY) mengingat kadar C-peptida dalam batas normal. DM tipe 1 disebabkan oleh karena kerusakan sel beta pankreas akibat adanya autoantibodi terhadap pankreas. Sedangkan MODY disebabkan oleh mutasi genetik pada sel â pankreas sehingga terjadi inefektifitas produksi atau gangguan pelepasan insulin. Pemeriksaan tambahan seperti deteksi antibodi sel islet disarankan untuk menetapkan diagnosis DM tipe 1, dan pemeriksaan genetik untuk mendeteksi terjadinya mutasi sel â pankreas. SimpulanDiagnosis Type-1 Diabetes mellitu, dengan diagnosis banding Maturity onset diabetes of the young(MODY)Kata Kunci: hiperglikemia anak, C-peptida, Diabetes mellitus tipe-1, MODY

APA, Harvard, Vancouver, ISO, and other styles

6

Santulli, G. "Thrombolysis Outcomes in Acute Ischemic Stroke Patients With Prior Stroke and Diabetes Mellitu." Neurology 78, no. 11 (March 13, 2012): 840. http://dx.doi.org/10.1212/wnl.0b013e31824de51b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dielievska, V. Yu, and I. P. Dunaeva. "AUTOIMMUNE MECHANISMS OF CHRONIC HEART FAILURE PROGRESSION IN ARTERIAL HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CONCOMITANT TYPE 2 DIABETES MELLITU." Problems of Endocrine Pathology 55, no. 1 (March 2, 2016): 23–28. http://dx.doi.org/10.21856/j-pep.2016.1.03.

Full text

Abstract:

We examined whether autoantibodies against type IV collagen are associated with heart failure progression in arterial hypertension combined with chronic obstructive pulmonary disease with and without type 2 diabetes mellitus. Both patients with chronic heart failure in essential hypertension and chronic obstructive pulmonary disease and patients with concomitant type 2 diabetes mellitus showed higher levels of plasma type IV collagen autoantibodies in comparison to healthy controls. Type IV collagen antibodies correlated with dilation of the left ventricle and reduction of its contractility. Elevation of plasma type IV collagen autoantibodies is associated with progression of chronic heart failure in arterial hypertension combined and chronic obstructive pulmonary with and without type 2 diabetes mellitus.

APA, Harvard, Vancouver, ISO, and other styles

8

Zilli Réus, Gislaine, Maria Augusta Bernardini dos Santos, Helena Mendes Abelaira, Amanda Luis Maciel, Camila Orlandi Arent, Beatriz Iladi Matias, Lívia Bruchchen, et al. "Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitu s." Current Neurovascular Research 13, no. 2 (March 31, 2016): 107–14. http://dx.doi.org/10.2174/1567202613666160219115832.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Shi, L., X. Ye, M. Lu, E. Q. Wu, H. Sharma, D. Thomason, and V. Fonseca. "Economic Outcomes Associated With Hba1c And Ldl-C Goal Achievement In Patients With Type 2 Diabetes Mellitu." Value in Health 16, no. 3 (May 2013): A172. http://dx.doi.org/10.1016/j.jval.2013.03.863.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

González-Escobar, Dianne Sofía, and Olga Marina Vega-Angarita. "Comparación entre la habilidad de cuidado de cuidadores de pacientes con enfermedad cerebrovascular Y diabetes mellitus en san josé de cúcuta, norte de santander." Respuestas 12, no. 2 (May 16, 2016): 5–17. http://dx.doi.org/10.22463/0122820x.559.

Full text

Abstract:

Objetivo:Comparar la habilidad de cuidado de los cuidadores familiares de pacientes por Diabetes Mellitus y Enfermedad Cerebrovascular en San José de Cúcuta, Norte de Santander. Materiales y Métodos:Corresponde a un diseño de tipo descriptivo comparativo con abordaje cuantitativo en 128 cuidadores familiares de pacientes (64 por Enfermedad Cerebrovascular y 64 por Diabetes mellitus). Resultados:Contienen la descripción de los grupos a estudio en términos de sexo, edad, nivel de escolaridad, estado civil, ocupación, nivel socioeconómico, cuidado desde el momento del diagnóstico, tiempo de cuidado y parentesco con la persona cuidada; nivel de funcionalidad del receptor de cuidado de acuerdo con su capacidad física y cognitiva. El nivel de habilidad total y de sus dimensiones: Conocimiento, Valor y Paciencia se comparan en los dos grupos de cuidadores. El estudio reporto similitud en las características sociodemográficas de la población participante, como en el nivel de funcionalidad de los receptores de cuidado. Discusión:Los hallazgos del estudio confirman lo reportado en la literatura de enfermería respecto a las características sociodemográficas y niveles deficientes en la habilidad de cuidado. En cuanto a los componentes que integran la habilidad de cuidado: conocimiento, valor y paciencia, se encuentran diferencias estadísticamente significativas entre los dos grupos, reportando los cuidadores familiares de pacientes diabéticos mayores niveles de conocimiento y paciencia. Respecto al componente valor no se encontró diferencia significativa entre los grupos a estudio.Palabras Clave : Cuidadores; Habilidad; Enfermedad Cerebrovascular; Diabetes Mellitus. SUMMARY Objective : To compare the care ability among the family caretakers of patients with Mellitus Diabetes and Cerebral Vascular diseases in San Jose de Cucuta, Norte de Santander. Materials And Methodology: It corresponds to a descriptive and comparative type of quantitative approach among the family caretakers of 64 Cerebral Vascular disease and 64 Mellitus Diabetes disease patients.Results: It contents a description of the study groups about the gender, age, school level, civil status, occupation, socio-economical level, time and care of the patient from diagnosis, kinship, and the level of potential functions on the receptor of the care according to their physical and cognitive capacities. The level of the total ability and its dimensions such as Knowledge, Courage and Patience are compared between the caretakers groups. The study showed similarity in the socio-demographic characteristics of the participants, as of in the level of potential functions on the receptors of the care.Argument: The findings of the study confirmed what was reported in the nursing literature regarding the socio-demographic characteristics and the shortcomings RESPUESTAS - Año 12 No. 2 - Diciembre 2007 ISSN 0122820X of the ability of the care given. In the components that integrate the ability to take care of the patient such as knowledge, courage and patience, significant statistic differences were found between the two groups, reporting mayor levels of knowledge and patience among the family caretakers of the diabetes patients. Regarding the component of courage, there were no significant differences between the groups of the study.Key Words: Caretakers, Ability, Cerebrovascular Accident, Diabetes Mellitu

APA, Harvard, Vancouver, ISO, and other styles

11

Wysocki, Tim, Michael A. Harris, Peggy Greco, Linda M. Harvey, Kelly McDonell, Caroline L. Elder Danda, Jeanne Bubb, and Neil H. White. "Social Validity of Support Group and Behavior Theraphy Intervetions for Families of Adolescents with Insulin-Dependent Diabetes Mellitu." Journal of Pediatric Psychology 22, no. 5 (1997): 635–49. http://dx.doi.org/10.1093/jpepsy/22.5.635.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Azimova, Makka R., and Julia V. Zhernakova. "Possibilities of a new glucagon-like peptide-1 receptor agonist Semaglutide in improving left ventricular diastolic function in a patient with arterial hypertension and type 2 diabetes mellitu." Systemic Hypertension 18, no. 4 (December 15, 2021): 186–92. http://dx.doi.org/10.26442/2075082x.2021.4.201305.

Full text

Abstract:

The emergence of new classes of glucose-lowering drugs that can further reduce cardiovascular risk (CVR) have fundamentally changed the approach to the management of patients with type 2 diabetes mellitus. The most significant changes concerned the strategy of choosing glucose-lowering therapy with a change in priorities from the glycemia level to CVR, which plays a key role in choosing a class of antidiabetic drugs. At the same time, the mechanisms responsible for lowering CVR remain largely unclear. Of undoubted interest is the study of effects of a new glucagon-like peptide-1 receptor agonist, Semaglutide, on the preclinical stage of diastolic dysfunction. The article presents a clinical case of the use of Semaglutide in a patient with arterial hypertension and type 2 diabetes mellitus.

APA, Harvard, Vancouver, ISO, and other styles

13

Habib, Tamanna Binte, Qazi Shamima Akhter, Hasan Imam, Nahid Yeasmin, Sharmin Nahar, and Farhana Rahman. "The potential benefit of omega-3 fatty acid capsule on Mean platelet volume and Platelet count in type-2 Diabetes Mellitu." Bangladesh Critical Care Journal 8, no. 1 (June 20, 2020): 37–40. http://dx.doi.org/10.3329/bccj.v8i1.47707.

Full text

Abstract:

Background: Diabetes Mellitus (DM) is a major non-communicable health problem that has effects on glycemic status. Hyperglycemia that is an inherent finding of diabetes causes platelet dysfunction. Oral omega-3 fatty acid supplementation may improve glycemic status in diabetic patient and reduce micro and macrovascular complications. Objective: To observe the effect of supplementation of omega-3 fatty acid on Mean Platelet Volume (MPV) and Platelet count in type 2 DM. Methods: A prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients of both sexes were selected within age 40 to 50 years. Among them, 27 type 2 diabetic patients with supplementation of omega 3 fatty acid (2g/day) for 12 weeks were considered as study group and another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid were considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city. MPV and platelet count were measured by hematology analyzer. The study parameters were measured at base line and after 12 weeks of study period in both groups. Results: In this study MPV and platelet count levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, MPV and platelet count were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to control group. In control group, MPV and Platelet count were almost similar both at baseline and after 3 months of follow-up. Conclusion: After analyzing the results of the study it can be concluded that omega-3 fatty acid may improve MPV and Platelet count levels in type 2 diabetic patients and may be helpful to minimize the complications of type-2 DM. Bangladesh Crit Care J March 2020; 8(1): 37-40

APA, Harvard, Vancouver, ISO, and other styles

14

Makwana, Dr Piyush, and Dr Anju Mehta. "Knowledge, Attitude and Practice Regarding Diabetes Mellitus in Diabetic and Non Diabetic Population." International Journal of Scientific Research 2, no. 10 (June 1, 2012): 1–3. http://dx.doi.org/10.15373/22778179/oct2013/94.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Pareek, Jitendra, and Kashyap Buch. "Prevalence of Diabetic Retinopathy in Diabetes Mellitus Patients in Bhuj, Kutch." Indian Journal of Emergency Medicine 4, no. 3 (2018): 137–40. http://dx.doi.org/10.21088/ijem.2395.311x.4318.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Singh, Luxmi, Lubna Ahmed, Swati Yadav, Pragati Garg, and B. B. Lal. "DIABETIC MACULAR EDEMA IN ASSOCIATION WITH DIABETIC RETINOPATHY IN PATIENTS OF TYPE 2 DIABETES MELLITUS." ERA'S JOURNAL OF MEDICAL RESEARCH 5, no. 1 (June 2018): 06–08. http://dx.doi.org/10.24041/ejmr2018.55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Siswoko, Siswoko, Cipto Cipto, and Teguh Wahyudi. "Risiko Preeklamsi Pada Ibu Hamil dengan Penyakit Penyerta." Jurnal Studi Keperawatan 3, no. 1 (March 22, 2022): 22–27. http://dx.doi.org/10.31983/j-sikep.v3i1.8371.

Full text

Abstract:

Latar belakang : Salah satu penyebab utama kematian Ibu di Indonesia disamping perdarahan adalah preeklamsia atau eklamsia. Kejadian preeklamsi belum diketahui secara jelas factor penyebabnya, namun kondisi tersebut sering dijumpai pada ibu hamil dengan riwayat penyakit penyerta seperti diabetes mellitus dan hipertensi.Tujuan : Studi ini menganalisa tentang seberasa besar risiko ibu hamil dengan penyakit penyerta (diabeter mellitus dan atau hipertensi) mengalami preeklamsi.Metode : studi ini menggunakan penelitian analitik kasus kontrol yang merupakan salah satu bentuk rancangan penelitian analitik dengan pendekatan waktu retrospektif dengan mengobservasi 600 data proses perjalanan penyakit hipertensi, diabetes mellitus dan kejadian preeklamsia pada ibu bersalin ke arah belakang tanpa melakukan intervensi.Hasil : Hasil penelitian menunjukkan dua variabel yang bermakna menjadi faktor pencetus terjadinya preeklamsia pada ibu bersalin yaitu riwayat hipertensi (OR = 2,149; CI= 95%) riwayat diabetus mellitus (OR = 6,682 ; CI = 95%).Kesimpulan : Ibu hami dengan penyakit penyerta hipertensi berisiko 2,149 kali mengalami preeklamsi dibandingan dengan ibu hamil tanpa hipertensi. Ibu hamil dengan diabetes mellitus berisiko 6,682 kali mengalami preeklamsi dibandingkan dengan ibu hamil tanpa penyakit penyerta diabetes mellitus. Keywords: preeklamsi, ibu hamil, hipertensi, diabetes melitus

APA, Harvard, Vancouver, ISO, and other styles

18

Dr. Vanitha Gowda M. N, Dr Vanitha Gowda M. N., Dr Kusuma K. S. Dr. Kusuma K. S, and Dr Vasudha K. C. Dr. Vasudha. K. C. "Serum Paraoxonase (Arylesterase) activity in Type 2 Diabetes Mellitus and diabetic nephropathy." Indian Journal of Applied Research 3, no. 4 (October 1, 2011): 351–53. http://dx.doi.org/10.15373/2249555x/apr2013/115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Unni, Shiju Raman, Hani Naguib, and Mary Mccallum. "Knowledge, Beliefs and Practices of People diagnosed with Type-1 Diabetes towards Diabetes Mellitus and Diabetic Foot Syndrome." Diabetes and Islet Biology 5, no. 1 (January 11, 2022): 01–08. http://dx.doi.org/10.31579/2641-8975/025.

Full text

Abstract:

Background: Diabetes Mellitus (DM) is associated with significant morbidity and mortality. Diabetic foot syndrome is one of the most common devastating preventable complications of diabetes mellitus (DM). Objectives: We aimed to evaluate the knowledge, Beliefs and Practices (KBP) among Omani patients with type 1 diabetes mellitus (T1DM) regarding DM and Diabetes foot. Design: A cross sectional descriptive study was used. Settings: A secondary care, polyclinic named Bawshar in Muscat, Oman where patients were seen three days per week. Sample Size:A convenient sample of 100 participants between age group 16 to 30 years were involved. Materials and methods: A validated semi- structured questionnaire was used to assess KBP of T1DM with six domains. During the study period from November 2019 to December 2019. .The data was analysed by using Statistical Package for the Social Sciences (SPSS) Statistics Inc., Chicago, US version 20. Results: There were 50 females, 50 males; 5 % of patients were illiterate and 30% of them were working. 65% were students. Only 50% checked their foot regularly and only 55% check there blood glucose regularly .57% don’t know the cause of diabetes, 25% don’t know the complications of the same while 20% don’t know cause of diabetic foot and 25% don’t know the symptoms of diabetic foot. 20% beliefs checking blood glucose is the responsibility of the doctor and 85% beliefs walking bare foot is high risk factor for DM foot. Conclusions: In reality healthcare providers must be trained to counsel people with DM to plan adequate interventions that enable an understanding of the offered information. A well-structured ,Behaviour change counselling (BCC) like Motivational interviewing (MI)are considered the ideal practices for this patients, to prevent DM complications.

APA, Harvard, Vancouver, ISO, and other styles

20

Raju Taklikar, Anupama. "Prevalence of Diabetic Retinopathy in Newly Diagnosed Cases of Type 2 Diabetes Mellitus." Ophthalmology and Allied Sciences 6, no. 1 (April 1, 2020): 9–11. http://dx.doi.org/10.21088/oas.2454.7816.6120.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Magnani, Guest Editors: L., G. Beltramello, D. Brancato, A. Fontanella, and R. Nardi. "L’internista ospedaliero nella gestione del paziente diabetico complesso." Italian Journal of Medicine 6, no. 1 (April 27, 2018): 1. http://dx.doi.org/10.4081/itjm.q.2018.2.

Full text

Abstract:

L’internista deve occuparsi (e rioccuparsi) del paziente diabetico complesso in OspedaleA. Fontanella, L. MagnaniDiagnosi, classificazione, epidemiologia clinica del diabete mellitoV. Provenzano, D. BrancatoUp-date degli studi disponibiliP. Gnerre, T.M. Attardo, A. Maffettone, G. BeltramelloIl diabete mellito costituisce ancora un equivalente di rischio cardiovascolare?G. Augello, T.M. AttardoLe terapie del diabete tipo 2 sono tutte uguali ai fini della riduzione della morbilità e mortalità cardiovascolare?V. ProvenzanoLe nuove tecnologie nella cura del diabete mellitoD. Brancato, V. ProvenzanoInsuline prandiali e insuline basaliR. PastorelliQuali target nel diabete mellito: il dogma dell’emoglobina glicata è davvero imprescindibile?V. ManicardiIl controllo dell’iperglicemia nel paziente anziano polipatologico: è sempre necessario iniziare l’insulina?G. Gulli, M. NizzoliLa nefropatia diabeticaF. Salvati, D. Manfellotto, M. StornelloCirrosi epatica e diabeteM. Imparato, L. FontanellaLa terapia personalizzata nel diabete di tipo 2A. Maffettone, C. Peirce, M. RinaldiLa gestione dell’iperglicemia nel paziente critico e instabileC. NozzoliLa disfunzione erettile nel paziente diabetico di tipo 2N. Artom, A. Bosio, G. PinnaQuali obiettivi di approccio integrato nella gestione del diabete mellito?E. Romboli, D. PanuccioIperglicemia, normoglicemia ed ipoglicemia nei pazienti anziani fragili: situazioni a rischio, politerapia e comorbilitàA. Greco, M. Greco, D. Sancarlo, F. Addante, G. D’Onofrio, D. Antonacci, S. De CosmoL’impatto clinico-prognostico dell’ipoglicemia nel paziente ospedalizzatoV. Borzì, L. Morbidoni, A. FontanellaL’internista chiamato in consulenza per un diabete gestazionale: quale approccio pragmatico?P. Novati, L. SaliLa frugalità nella gestione del diabete mellito: qualità assistenziale, governo clinico e costi correlatiP. Gnerre, G. Carta, D. MontemurroLa gestione dell’iperglicemia in area medica, ma senza esagerare.L. Magnani, G. BeltramelloAPPENDICE IUn approccio pragmatico per la valutazione globale e la gestione del paziente diabeticoF. Pieralli, A. Crociani, C. BazziniAPPENDICE IILe insuline e i farmaci ipoglicemizzanti orali disponibiliP. Zuccheri, L. Alberghini, E. SoraAPPENDICE IIILe scale di correzione insulinica: pro e controV. Borzì

APA, Harvard, Vancouver, ISO, and other styles

22

Piťhová, Pavlína. "Diabetic patient in a general practitioner's office - part 1 Type 2 diabetes mellitus and its treatment." Medicína pro praxi 18, no. 2 (April 30, 2021): 104–11. http://dx.doi.org/10.36290/med.2021.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sinyangwe, Emmanuel, Herbert Tato Nyirenda, and Victor Mwanakasale. "Knowledge, Attitudes and Behaviour Towards Diabetes Mellitus Among Diabetic Patients at Ndola Teaching Hospital." Asian Pacific Journal of Health Sciences 4, no. 3 (September 30, 2017): 34–42. http://dx.doi.org/10.21276/apjhs.2017.4.3.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Garg, Prof Pragati. "Prevalence of various stages of Diabetic Retinopathy in patients of Diabetes Mellitus-Type 2." Journal of Medical Science And clinical Research 04, no. 12 (December 24, 2016): 14903–8. http://dx.doi.org/10.18535/jmscr/v4i12.97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Robalino, Raquel, María Robalino, Amelia Cano, Rosa Chilquina, and Marcia Aldaz. "CARACTERIZACIÓN CLINICOEPIDEMIOLÓGICA DE ADULTOS CON DIABETES MELLITUS PERTENECIENTES AL CLUB DE DIABÉTICO DE RIOBAMBA." Revista de Investigación Talentos 7, no. 1 (June 30, 2020): 114–24. http://dx.doi.org/10.33789/talentos.7.1.128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

GÜRBÜZ, Murat, and Menşure Nur ÇELİK. "Minerals and Diabetes Mellitus." Turkiye Klinikleri Journal of Internal Medicine 4, no. 2 (2019): 71–83. http://dx.doi.org/10.5336/intermed.2018-64388.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Anderlová, Kateřina. "Screening for gestational diabetes mellitus." Vnitřní lékařství 67, no. 6 (October 13, 2021): 366–67. http://dx.doi.org/10.36290/vnl.2021.094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Anderlová, Kateřina. "Screening for gestational diabetes mellitus." Vnitřní lékařství 67, no. 6 (October 13, 2021): 366–67. http://dx.doi.org/10.36290/vnl.2021.094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Chaudhary, Nitin, and Nidhi Tyagi. "Diabetes mellitus: An Overview." International Journal of Research and Development in Pharmacy & Life Sciences 7, no. 4 (August 2018): 3030–33. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2018.7(4).3030-3033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Ambulkar, Sunil, Parimal Tayde, Makarand Randive, and Mukund Ganeriwal. "Diabetes mellitus in pregnancy." New Indian Journal of OBGYN 4, no. 1 (July 2017): 4–9. http://dx.doi.org/10.21276/obgyn.2017.4.1.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Еловикова, Т., and T. Elovikova. "CRYSTALLOGRAPHIC CHARACTERISTICS OF GINGIVAL FLUID OF PATIENTS WITH DIABETES MELLITUS TYPE 1." Actual problems in dentistry 9, no. 5 (October 25, 2013): 8–11. http://dx.doi.org/10.18481/2077-7566-2013-0-5-8-11.

Full text

Abstract:

<span style="font-size: 14.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: Calibri; letter-spacing: .2pt; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">C</span><span style="font-size: 14.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: Calibri; letter-spacing: .35pt; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">rystallographi</span><span style="font-size: 14.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">c <span style="letter-spacing: .35pt;">charac</span><span style="letter-spacing: .25pt;">t</span><span style="letter-spacing: .35pt;">eristic</span>s <span style="letter-spacing: .25pt;">o</span>f <span style="letter-spacing: .35pt;">gingiva</span>l <span style="letter-spacing: .35pt;">flui</span>d <span style="letter-spacing: .25pt;">o</span>f <span style="letter-spacing: .35pt;">patient</span>s <span style="letter-spacing: .35pt;">wit</span>h <span style="letter-spacing: .35pt;">diabe</span><span style="letter-spacing: .25pt;">t</span><span style="letter-spacing: .35pt;">e</span>s <span style="letter-spacing: .35pt;">mellitu</span>s <span style="letter-spacing: .35pt;">typ</span>e1<span style="letter-spacing: .35pt;">i</span>n <span style="letter-spacing: .35pt;">100</span>% <span style="letter-spacing: .25pt;">o</span>f <span style="letter-spacing: .35pt;">case</span>s <span style="letter-spacing: .15pt;">c</span><span style="letter-spacing: .35pt;">or</span><span style="letter-spacing: .4pt;">r</span><span style="letter-spacing: .35pt;">ela</span><span style="letter-spacing: .25pt;">t</span><span style="letter-spacing: .35pt;">e</span>d <span style="letter-spacing: .35pt;">wit</span>h <span style="letter-spacing: .35pt; mso-font-width: 94%;">s</span><span style="letter-spacing: .2pt; mso-font-width: 94%;">e</span><span style="letter-spacing: .25pt; mso-font-width: 94%;">v</span><span style="letter-spacing: .35pt; mso-font-width: 94%;">e</span><span style="letter-spacing: .4pt; mso-font-width: 94%;">r</span><span style="letter-spacing: .35pt; mso-font-width: 94%;">it</span>y <span style="letter-spacing: .25pt;">o</span>f <span style="letter-spacing: .35pt;">perio</span><span style="letter-spacing: .4pt;">d</span><span style="letter-spacing: .35pt;">ontit</span>s <span style="letter-spacing: .35pt;">an</span>d <span style="letter-spacing: .15pt;">f</span><span style="letter-spacing: .25pt;">orm</span>s a <span style="letter-spacing: .25pt;">pictur</span>e <span style="letter-spacing: .15pt;">o</span>f <span style="letter-spacing: .25pt;">th</span>e <span style="letter-spacing: .25pt;">sta</span><span style="letter-spacing: .15pt;">t</span>e <span style="letter-spacing: .15pt;">o</span>f <span style="letter-spacing: .25pt;">adapti</span><span style="letter-spacing: .15pt;">v</span>e <span style="letter-spacing: .25pt;">pro</span><span style="letter-spacing: .05pt;">c</span><span style="letter-spacing: .25pt;">esse</span>s <span style="letter-spacing: .25pt;">in </span><span style="letter-spacing: .1pt;">th</span>e <span style="letter-spacing: .1pt; mso-font-width: 95%;">periodontium</span>. <span style="letter-spacing: -.3pt; mso-font-width: 160%;">R</span><span style="letter-spacing: .1pt; mso-font-width: 98%;">esearc</span>h of <span style="letter-spacing: .1pt;">parame</span>t<span style="letter-spacing: .1pt;">er</span>s j<span style="letter-spacing: .1pt;">appropria</span>te <span style="letter-spacing: -.2pt; mso-font-width: 96%;">c</span><span style="letter-spacing: .05pt; mso-font-width: 96%;">onduc</span>t <span style="letter-spacing: .05pt;">a</span>s <span style="letter-spacing: .05pt;">a</span>n <span style="letter-spacing: .05pt; mso-font-width: 93%;">obj</span><span style="letter-spacing: -.05pt; mso-font-width: 93%;">e</span><span style="letter-spacing: .05pt; mso-font-width: 93%;">cti</span><span style="letter-spacing: -.05pt; mso-font-width: 93%;">v</span>e <span style="letter-spacing: .05pt;">морф</span><span style="letter-spacing: -.1pt;">от</span><span style="letter-spacing: -.05pt;">е</span><span style="letter-spacing: -.1pt;">с</span><span style="letter-spacing: .05pt;">т</span>а <span style="letter-spacing: -.05pt;">f</span><span style="letter-spacing: .05pt;">o</span>r <span style="letter-spacing: .05pt;">earl</span>y<span style="letter-spacing: .05pt;">diagnostics </span>of <span style="letter-spacing: .1pt; mso-font-width: 94%;">inflamma</span>t<span style="letter-spacing: .1pt;">or</span>y <span style="letter-spacing: .1pt;">pro</span><span style="letter-spacing: -.1pt;">c</span><span style="letter-spacing: .1pt;">es</span>s <span style="letter-spacing: .1pt;">i</span>n <span style="letter-spacing: .1pt; mso-font-width: 97%;">periodonta</span>l <span style="letter-spacing: .1pt;">tissue</span>s<span style="letter-spacing: .1pt;">an</span>d <span style="letter-spacing: .1pt;">also th</span>e f<span style="letter-spacing: .1pt;">or</span>e<span style="letter-spacing: .1pt;">cas</span>t of <span style="letter-spacing: .1pt;">illness.</span></span>

APA, Harvard, Vancouver, ISO, and other styles

32

K, Madhavan. "Study on Mean Platelet Volume in Type 2 Diabetes Mellitus Patients vs Non Diabetic Patients." Journal of Medical Science And clinical Research 05, no. 03 (March 8, 2017): 18573–77. http://dx.doi.org/10.18535/jmscr/v5i3.51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Doamekpor, Caleb. "Diabetes Mellitus." Acta Scientific Pharmaceutical Sciences 4, no. 2 (January 31, 2020): 01–09. http://dx.doi.org/10.31080/asps.2020.04.diabetes-mellitus.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Poskerová, H., P. Linhartová, J. Vokurka, A. Fassmann, and L. Hollá. "Diabetes Mellitus and Oral Health." Česká stomatologie/Praktické zubní lékařství 114, no. 5 (December 1, 2014): 75–86. http://dx.doi.org/10.51479/cspzl.2014.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Malinovská, Jana, Jana Urbanová, Michala Lustigová, Kristýna Kučera, and Jan Brož. "Diabetes mellitus and illicit drugs." Vnitřní lékařství 66, no. 5 (August 1, 2020): e16-e19. http://dx.doi.org/10.36290/vnl.2020.092.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Vohnout, Branislav, Jana Lisičanová, and Andrea Havranová. "PCSK9 inhibitors and diabetes mellitus." Vnitřní lékařství 64, no. 12 (December 1, 2018): 1186–89. http://dx.doi.org/10.36290/vnl.2018.170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Poskerová, H., P. Linhartová, J. Vokurka, A. Fassmann, and L. Hollá. "Diabetes Mellitus and Oral Health." Česká stomatologie/Praktické zubní lékařství 114, no. 5 (December 1, 2014): 75–86. http://dx.doi.org/10.51479/cspzl.2014.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Piťhová, Pavlína, and Lucie Růžičková Jarešová. "Skin changes in diabetic patients." Dermatologie pro praxi 14, no. 3 (October 20, 2020): 136–41. http://dx.doi.org/10.36290/der.2020.025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Vachek, Jan, Oskar Zakiyanov, and Vladimír Tesař. "Recommendations for care of patients with diabetes and kidney impairment." Interní medicína pro praxi 18, no. 3 (July 1, 2016): 130–33. http://dx.doi.org/10.36290/int.2016.030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Goldmannová Ondřej Krystyník David Karásek, Dominika, and Josef Zadražil. "Diabetes mellitus after organ transplantation." Interní medicína pro praxi 21, no. 1 (February 21, 2019): 20–23. http://dx.doi.org/10.36290/int.2019.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Padmasri Devi, P., M. Mahalakshmi, V. Sarojini Devi, M. Kiran Deedi, Ch Ganapathi Swamy, and V. Thoyoja Durga. "Prevalence of Gestational Diabetes Mellitus." Indian Journal of Obstetrics and Gynecology 7, no. 2 (2019): 309–11. http://dx.doi.org/10.21088/ijog.2321.1636.7219.31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

HRRao, Gundu. "Hyperglycaemia, Dyslipidaemia and Diabetes Mellitus." Diabetes & Obesity International Journal 4, no. 2 (2019): 1–6. http://dx.doi.org/10.23880/doij-16000198.

Full text

Abstract:

Diabetes is a chronic, complex disease of lifestyle, known to mankind for thousands of years. It is a metabolic disease in which, elevated blood glucose ultimately leads to various clinical complications including, retinopathy, nephropathy, neuropathy, a variety of vascular diseases and, end organ failure. According to the experts, high blood sugar is just a symptom and not the cause for the disease. Major cause for this disease is, impaired insulin production, or insulin insensitivity. Diabetes is supposed to usually begin with insulin resistance, a condition in which, muscle, liver and fat cells do not use insulin efficiently. Sedentary nature, diet and excess weight, seem to contribute significantly to the development of diabetes. A quick Internet search on diabetes management reveals that by and large clinicians focus on fasting glucose, glucose intolerance, postprandial glucose peaks, or glycosylated haemoglobin (HBA1c) levels. Experts are of the opinion, that there is no cure for the diabetes, but it can be managed and controlled. The guidelines and guidance statements from professional societies, also emphasize heavily on the management of blood glucose levels and suggest that these levels be kept at as near to normal levels as possible, by balancing food intake and medication.In this short overview, we will discuss some salient features related to chronic complications of diabetes and express our point of view, on the two major players, hyperglycaemic load and dyslipidaemia, that contribute significantly to the chronic complications associated with diabetes.

APA, Harvard, Vancouver, ISO, and other styles

43

Iqbal, Rana Khalid. "Genetic Factors of Diabetes Mellitus." Diabetes & Obesity International Journal 4, no. 4 (2019): 1–7. http://dx.doi.org/10.23880/doij-16000213.

Full text

Abstract:

Diabetes mellitus is a disease in which pancreas fail to perform its work. In this condition, insulin is not produced in the amount as required for the normal function of the body. This led to different complication. And the results of many different diseases like kidney failure, high blood pressure, urination, blindness, stroke, heart attack, muscle dysfunction. Diabetes mellitus has two types: first is known as type 1 diabetes or Insulin-dependent diabetes. Second is known as type 2 diabetes or Non-insulin dependent diabetes mellitus. Most important is genetics which plays an important role in the development of diabetes. Other is environmental factors which are responsible for causing of disease by changing the gene patterns. In genetics, different genes are responsible for the causing of diabetes and these genes are present at a different position on a chromosome. In type 1 diabetes chromosome 6 and HLA complex, viral infection, physiological factors, environmental factors, and 60 genes are identified for causing of this disease. In type 2 diabetes environmental factor, 120 genetic loci, E23K polymorphism in the KCNG11 gene, Glucokinase gene mutation, epigenetics, TCF722, ABCC8, CAPN10, GIUT2, genes are responsible for the causing of disease of type 2 diabetes.

APA, Harvard, Vancouver, ISO, and other styles

44

DEVI, Yuli Puspita, Rumaisah ABDILLAH, and Muthmainnah MUTHMAINNAH. "DETERMINANTS OF GESTATIONAL DIABETES MELLITUS." PERIÓDICO TCHÊ QUÍMICA 18, no. 37 (March 20, 2021): 48–56. http://dx.doi.org/10.52571/ptq-v18-n73-pgi.48-2021.

Full text

Abstract:

Background: Gestational Diabetes Mellitus (GDM) is a glucose tolerance disorder that first appears during pregnancy. GDM can cause a variety of obstetric and perinatal complications for pregnant women and their fetuses. The prevalence of GDM in the city of Surabaya in 2015 amounted to 2.29%, increasing to 3.88% in 2018. Aim: The purpose of this study was to analyze the determinants (family history of diabetes mellitus, BMI, history of birth weight, parity, and the age of the pregnant woman) that influence the GDM. Methods: This research is an analytical study with an observational approach. The research design was carried out using a case-control study. In this study, the number of samples was 36 people, 6 cases, and 30 people as controls, and were taken randomly. The data source obtained from secondary data (medical records of pregnant women) at Mulyorejo Health Center Surabaya. The analysis used in this study was a simple logistic regression test. Results and Discussion: The result showed an effect of a family history of diabetes mellitus (p = 0.035) on the incidence of GDM. Parity was a potential variable (p = 0.077) on the incidence of GDM. Meanwhile, BMI, history of birth weight, and mother's age did not affect the incidence of GDM. Conclusion: Pregnant women with a family history of diabetes who are not balanced with maintaining a good lifestyle can experience complications of developing GDM.

APA, Harvard, Vancouver, ISO, and other styles

45

Pelikánová, Terezie. "Diabetes mellitus and cardiovascular diseases." Cor et Vasa 53, no. 4-5 (April 1, 2011): 242–48. http://dx.doi.org/10.33678/cor.2011.054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Sarma, Dr Jayanta Kumar. "Yoga for Madhumeha (Diabetes Mellitus)." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 06, no. 2 (June 15, 2016): 40–41. http://dx.doi.org/10.58739/jcbs/v06i2.7.

Full text

Abstract:

Ayurveda describes Madhumeha under Asth-amagada (eight major diseases) and is one of the oldest documented disease. It is described as a disease in which the patients urine is sweet as honey, quantitatively increased and of Kashaya rasa, Aruna varna and Ruksha in guna or quality. Since the ancient times management of Madhumeha has been through a multi-pronged approach with includes diet modifica-tion, drug prescription, behaviour modification and control of psychosomatic factors. Modern life style though physically comfortable is men-tally stressful and is blended with faulty die-tary habits and poor physical activity which are risks for diabetes.[1]

APA, Harvard, Vancouver, ISO, and other styles

47

M.Al-Daghria, Nasser, Mohammed Ghouse AhmedAnsaria, Shaun Sabicoa, Yousef Al-Salehab, Naji J.Aljohaniac, Hanan Alfawazad, and Mohammed Alharbie. "A Review Based Study of Diabetic Complications: Meta-Analysis in people with type 2 Diabetes Mellitus." Endocrinology and Disorders 2, no. 1 (April 29, 2018): 01–04. http://dx.doi.org/10.31579/2640-1045/016.

Full text

Abstract:

The prevalence of diabetes (DM) is constantly increasing worldwide at an alarming rate. According to the International Diabetes Federation in 2015, an estimated 415 million people globally were suffering from this condition. Complications of DM account for increased morbidity, disability, and mortality and represent a threat for the economies of all countries, especially the developing ones. The present special issue has been devoted to the recent progress in our understanding of diabetic complications, including the underlying molecular mechanisms, new diagnostic tools that facilitate early diagnosis, and novel treatment options. This special issue focuses on progress and challenges in basic and clinical research on these chronic complications of diabetes. The end-stage consequences of diabetic complications can include severe vision loss; end-stage renal disease necessitating dialysis or transplant; myocardial infarction and stroke; and amputations. Many of these life-threatening or disabling events can be preventable with proper “life-long” diabetes care and a healthy lifestyle.

APA, Harvard, Vancouver, ISO, and other styles

48

Phir, Masiye, David Mulenga, Mazyanga L. Mazaba, and Seter Siziya. "Prevalence of Diabetes mellitus and association between knowledge of diabetes and Diabetes mellitus among police officers in Peter Singogo camp, Zambia." Asian Pacific Journal of Health Sciences 3, no. 3 (July 2016): 87–89. http://dx.doi.org/10.21276/apjhs.2016.3.3.14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

-, Rodiyah. "Pemeriksaan Kadar Gula Darah, Konseling Tentang Diabetes Mellitus Dengan Komplikasinya Di PSTW Jombang." Jurnal Pengabdian Masyarakat Kesehatan 7, no. 1 (September 30, 2020): 38–41. http://dx.doi.org/10.33023/jpm.v7i1.732.

Full text

Abstract:

Indonesia merupakan Negara terbanyak ke empat di dunia untuk jumlah penderita terbanyak diabetes mellitus setelah India, Cina dan Amerika Serika. Diabetes melitus merupakan suatu kumpulan problema anatomik dan kimiawi yang merupakan akibat dari sejumlah faktor. Pasien dengan Diabetus Mellitus biasanya datang ke pelayanan kesehatan dengan komplikasi. Tujuan dari kegiatan ini membantu para Lansia dan masyarakat sekitar panti untuk dapat mengetahui kadar gula darahnya dan memberikan konseling tentang diabetes Mellitus di Unit Pelaksana Teknis Pelayanan Sosial Tresna Werdha Jombang. Pada kegiatan ini di dapatkan hasil pemeriksaan kadar gula darah 9 orang (20,5%) dalam kategori bukan DM, 26 orang ( 59%) dalam kategori belum pasti DM, dan 9 orang (20,5%) dalam kategori DM. Berdasarkan hasil dari pemeriksaan kadar gula darah diharapkan lansia dan masyarakat sekitar panti dapat lebih menerapkan pola hidup sehat seperti mengontrol pola makan, melakukan aktivitas fisik sesuai kemampuan dan juga bisa mengontrol kadar gula darahnya dengan pemeriksaan yang teratur. Bagi yang sudah terdeteksi menderita Diabetus mellitus diharapkan untuk selalu memeriksakan diri ke petugas kesehatan minimal 1 bulan sekali. Kata Kunci: Kadar Gula Darah, Konseling Diabetus Mellitus, Komplikasi

APA, Harvard, Vancouver, ISO, and other styles

50

Triwibowo, Cecep, Evi Nurjannah, Ikha Fitriyana, and Yulia Fauziyah. "Aerobic Exercise Decrease Cholesterol Levels in Type 2 Diabetes Mellitus Patients." Jurnal Keperawatan Soedirman 13, no. 1 (July 18, 2018): 8. http://dx.doi.org/10.20884/1.jks.2018.13.1.759.

Full text

Abstract:

<p>ElevatedÂ cholesterolÂ level is one ofÂ the risksÂ for cardiovascular diseaseÂ in diabetes mellitus. Exercise is one of therapy in patients with diabetes mellitus. The purpose of this study is to determine the effect of exercise on decrease cholesterol levels in patients with diabetes mellitus. This study used pre-post test one group design. Twenty-two patients with diabetes mellitus followed the intervention which is a twice a week exercise for 4 weeks. Cholesterol levels were measured before and after exercise. Data were analyzed byÂ dependent T-test. CholesterolÂ levels in patients with Â diabetesÂ mellitus beforeÂ the exercise reached 261.18Â±49.013 mg/dL and after intervention decreased to 224.41Â±26 mg/dL. Dependent t-test showed differences in cholesterol levels before and after exercise in patients with diabetes mellitus (p<0.05). Exercise can lower cholesterol levels in patients with diabetes mellitus.</p>

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!